Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, May 1998, p. 335-340, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cytokine Gene Expression in Normal Human
Lymphocytes in Response to Stimulation
Jiang
Fan,
Parunag
Nishanian,*
Elizabeth C.
Breen,
Matthew
McDonald, and
John L.
Fahey
Center for Interdisciplinary Research in
Immunology and Disease at UCLA and Jonsson Comprehensive Cancer
Center, UCLA School of Medicine, Los Angeles, California 90095-1747
Received 15 August 1997/Returned for modification 21 October
1997/Accepted 2 February 1998
 |
ABSTRACT |
Sequential gene expression of two type 1 cytokines (interleukin 2 [IL-2] and gamma interferon), one type 2 cytokine (IL-10), two
monokines (IL-6 and tumor necrosis factor alpha), and one cytokine
receptor (IL-2 receptor [IL-2R]) in normal human peripheral blood
mononuclear cells (PBMC) following in vitro stimulation was
investigated by reverse transcription-PCR methods. Two stimuli were
utilized: phytohemagglutinin (PHA), which acts on the CD2 molecule and
T-cell receptors, and anti-CD3 monoclonal antibody, which acts on the
CD3 molecule and on T-cell receptors. Increased expression of all
studied genes occurred between 1 and 4 hours after stimulation, except
for that of the gene encoding IL-10, which was delayed. Expression of
all but one of the genes was transient, with a maximal mRNA
accumulation at about 8 h on average. IL-2R mRNA expression was an
exception, showing a prolonged increase (72 h). The general profiles of
expression of the five cytokine genes were similar but not identical,
suggesting some shared regulatory mechanisms. When responses to four
additional stimuli (pokeweed mitogen, Candida albicans, and
IL-2 at high and low doses) were compared, similar profiles of cytokine
gene expression were found. Thus, the various stimuli caused induction
of all cytokines with quantitative, not qualitative, differences.
Altogether, the present data are useful for defining the kinetics of
gene expression for key cytokines in response to standard immune-cell
stimuli.
 |
INTRODUCTION |
T-cell activation can be initiated
by diverse agents such as antigens, plant mitogens, cytokines, and
monoclonal antibodies (29, 30, 42). These stimuli cause
complex series of ordered interactions and events, including activation
of transmembrane signaling pathways, cytokine gene expression,
transcription, and translation. Upon stimulation, properties like
stability and rate of synthesis of existing RNA and proteins are
altered, and synthesis of new RNA and proteins is initiated. The
outcomes of the activation process are T-cell proliferation and
differentiation and cytokine production.
Cytokines are important mediators in the regulation of the immune
response. The kinetics of gene expression and the production of several
cytokines following stimulation have been studied (3, 11, 14, 16,
26, 41, 42). Most data available concern the expression of and
the relationship between interleukin 2 (IL-2), IL-2 receptor (IL-2R),
and gamma interferon (IFN-
) (13, 14, 18-20, 26). The
production of cytokines and/or cytokine receptors in stimulated T cells
might be regulated either by common mechanisms or by independent
pathways. Conflicting data exist in the literature in support of both
options. Such disparate data might be due to the fact that the
different stimuli used resulted in different patterns of cytokine
and/or cytokine receptor mRNA production. Furthermore, the temporal
relationship of the expression of different cytokine genes after
stimulation with a variety of stimuli has not been well established.
In previous reports, cytokine mRNA expression in stimulated peripheral
blood mononuclear cells (PBMC) has been studied by using Northern blots
or nuclear transcription assays that are now recognized as moderately
sensitive. Since most cytokine genes are expressed transiently and at
low levels, in our present study we used reverse transcription
(RT)-PCR, which provides the most sensitive method for quantitation of
mRNA. In our study, cytokine gene expression for two Th1 cytokines
(IL-2 and IFN-
), one Th2 cytokine (IL-10), two monokines (IL-6 and
tumor necrosis factor alpha [TNF-
]), and one cytokine receptor
(IL-2R) were compared. Since different stimuli act on different cell
types and via different receptors, two stimuli were studied in
detail
phytohemagglutinin (PHA), which acts on the CD2 molecule and
T-cell receptors, and anti-CD3 monoclonal antibody, which acts on the
CD3 molecule and on T-cell receptors. Additional stimuli, including
another mitogen, a microbial antigen, and the cytokine IL-2, were also
evaluated. The kinetics of response were determined by sequential
testing of cytokine gene expression.
 |
MATERIALS AND METHODS |
Preparation of PBMC.
Fresh blood was obtained from healthy
adult volunteers under a protocol approved by the Human Subject
Protection Committee of UCLA School of Medicine. After Lymphoprep
(Nyegaard and Co., Oslo, Norway) density gradient centrifugation,
interface mononuclear cells were collected and washed three times with
Dulbecco's phosphate-buffered saline (Gibco, Grand Island, N.Y.). The
PBMC were suspended in RPMI 1640 (Gibco) with 10% human AB serum at
2 × 106 cells/ml in endotoxin-free tubes.
Cell cultures and proliferation assays.
Proliferation assays
were performed in 12 by 75-mm sterile tubes (Fisher) in triplicate. In
general, PBMC at 106 cells/tube in a total volume of 500 µl of RPMI 1640 supplemented with 10% human AB serum, 100 U of
penicillin per ml, 100 µg of streptomycin per ml, and 0.3 mg of
glutamine per ml were incubated with stimuli in 5% CO2 at
37°C. Stimuli were added to cultures after 1 h of cell resting.
Cultures with 5 µg of PHA (Sigma) per ml, 200 ng of anti-CD3 antibody
(NEN Research Products, Boston, Mass.) per ml, or pokeweed mitogen
(PWM; Gibco) at a 1:500 dilution were incubated for 3 days. Cultures
with Candida albicans (Greer Laboratories, Lenoir, N.C.) at
8 µg/ml or recombinant IL-2 (rIL-2; DuPont) at 10 or 1,000 U/ml were
incubated for 6 days. During the last 6 h of the appropriate
incubation time, cultures were pulsed with 1 µCi of
[3H]thymidine (ICN, Irvine, Calif.) per tube. Cells were
harvested on glass fiber filters with an automatic harvester (Cambridge Technology, Watertown, Mass.), and the incorporated radioactivity was
measured in a liquid scintillation counter (Beckman) after the addition
of 3 ml of scintillation fluid. Proliferation data were expressed as a
stimulation index: (counts per minute of stimulated cells)/(counts per
minute of nonstimulated cells).
For time course studies of cytokine and/or cytokine receptor gene
expression, aliquots of PBMC were cultured in the same way as for the
proliferation assay but without pulsing with tritiated thymidine.
Cultures were centrifuged after various stimulation times, and cells
were collected. At the end of the culturing period, no significant
changes in cell viability were observed when the cultures were tested
by the trypan blue exclusion method.
RNA isolation and cytokine and/or cytokine receptor mRNA
quantitation in cultured cells.
The procedures for RNA isolation
and RT-PCR quantitation, including data on linearity, reproducibility,
sensitivity, etc., and an optimal assay performance were described in
detail previously (15). Briefly, for RNA isolation and
reverse transcription, cells were lysed by guanidinium isothiocyanate
(4 M) in sodium citrate (25 mM) buffer, pH 7.0, with 0.5% sarcosyl and
0.1 M
-2-mercaptoethanol. For RNA isolation, 0.1 volume of 2 M
sodium acetate was added together with 1 volume of water-saturated
phenol and 0.2 volume of 49:1 chloroform-isoamyl alcohol. After
centrifugation, RNA was extracted in the aqueous phase and the
phenol-chloroform extraction was repeated once more. The RNA was then
precipitated with isopropanol at
20°C for 1 h. After
centrifugation, the pellet was washed with 70% ethanol twice and
dissolved in diethyl pyrocarbonate-treated water containing 20 µmol
of RNase inhibitor (9). Ten nanograms of total RNA was used
for each RT-PCR.
cDNA was synthesized from oligo(dT)-primed RNA by incubation at 42°C
for 15 min, and then at 99°C for 5 min and a soak at 5°C for 5 min
with Moloney murine leukemia virus reverse transcriptase (GIBCO,
Bethesda Research Laboratories) and 1 mM deoxynucleoside triphosphate.
For the semiquantitative PCR, the reaction mixture contained 10 mM
Tris-HCl, 2 mM MgCl2, 0.2 mM deoxynucleoside triphosphate, 0.2 µM 5' and 3' oligonucleotide primers, and 2.5 µmol of AmpliTaq DNA polymerase (Perkin-Elmer Cetus). Trace amounts (0.01 µM) of [
-32P]dATP were added. Aliquots were then amplified by
35 cycles (cytokines and cytokine receptor) or 25 cycles (
-actin) of
denaturation at 95°C for 1 min and annealing and extension at 60°C
for 1 min. The sequences of the primers used with cytokine-encoding
genes are shown in Table 1.
PCR products were analyzed by electrophoresis on a Tris-borate-EDTA
acrylamide gel and autoradiographed with a Hyperfilm-HP (Amersham). The
radioactive product bands were cut from the dried gel and quantified by
beta scintillation counting, and results were recorded as counts per
minute. All of the data regarding cytokine and cytokine receptor PCR
products in a sample were normalized according to the amount of
-actin detected in the same sample. The size (measured as adenosine
content) of the amplicons and the levels of maximum mRNA production for
different cytokines were not correlated. Thus, the measured
radioactivity levels (in counts per minute) generally represented the
cytokine mRNA concentrations without further corrections. For more
reliable comparison, in the time course experiments the quantitation of
cytokine and cytokine receptor mRNA induced by each of the two stimuli
used was performed in one set of experiments.
Statistical analysis.
Linear regression analysis was used to
evaluate the correlation between the proliferative stimulation index
and (i) the time when the first measurable change in the amount of
cytokine or cytokine receptor mRNA was found, (ii) the time when the
maximum amount of mRNA was reached and (iii) the maximum amount of
induced mRNA. The Kendall rank correlation method was used to assess
the correlation between the proliferation stimulation index and the cytokine or cytokine receptor level.
 |
RESULTS |
Cytokine and cytokine receptor mRNA production in unstimulated
PBMC.
Low levels of all cytokine genes were demonstrable by the
RT-PCR method in PBMC before culturing (Fig.
1). This production of mRNA could reflect
in vivo gene production or some activation during cell separation. To
examine these possibilities, PBMC from two subjects were cultured for
4, 8, 24, and 72 h without any stimuli added, and cytokine mRNA
production was measured. As shown in Table
2, the level of mRNA encoding all
cytokines in PBMC after resting (i.e., in a culture without added
stimuli) was significantly lower than the mRNA level immediately after
cell separation (with the exception of IL-2R mRNA from one subject).
Variations between amounts of different cytokine mRNA are evident, but
none of the mRNA amounts declined to zero (Table 2). Furthermore,
within 72 h, none of the cultures of unstimulated PBMC
demonstrated the maximum of cytokine gene expression at 8 h that
we consistently observed for PBMC stimulated with five different
stimuli, including IL-2 at two doses (one low and one high). Thus, low
but detectable mRNA levels, different for each cytokine and each
individual, were consistently found for all six cytokine mRNAs
examined.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Time course of cytokine mRNA production and accumulation
after stimulation. PBMC were stimulated with PHA (A) and with anti-CD3
monoclonal antibody (B). Total cellular RNA was isolated at the
indicated times after activation. mRNA encoding IL-2 ( ), IL-2R
( ), IL-6 ( ), IL-10 (×), TNF- (*), and IFN- ( ) was
measured by the semiquantitative RT-PCR method. Data for samples from
four healthy donors are presented as mean proportions of the maximal
amounts of each specific mRNA.
|
|
Time course of cytokine and cytokine receptor mRNA expression
following stimulation.
In order to define and compare the kinetics
of IL-2, IL-2R, IL-6, IL-10, TNF-
, and IFN-
gene expression
following in vitro stimulation, time course experiments were carried
out with PBMC from four healthy donors. Semiquantitative RT-PCR
analyses were used to determine the level of each cytokine mRNA at each
time point for each stimulus. The experimental results (in counts per minute) from each sample were adjusted for radioisotope decay and by
normalizing them to the sample's
-actin amount. The time course of
changes in mRNA levels for four healthy donors is presented as a mean
percent of the maximal mRNA level for each cytokine after stimulation
with PHA (Fig. 1A). Stimulation with anti-CD3 monoclonal antibody is
shown separately in Fig. 1B. Four features of the response were
evaluated: the time of induction, the time and the level of maximal
mRNA accumulation, and the rate of subsidence. The patterns of mRNA
production induced by PHA and by anti-CD3 were compared as well.
The initial increase is the first measurable response to stimulation
and is defined here by the earliest point in time, within the time
frame utilized in this study, that a 25% or greater increase in levels
of specific gene production compared to levels at time zero was found.
Genes encoding IFN-
, TNF-
, and IL-2 were the earliest induced
(within 1 h of incubation), regardless of the stimuli. The time of
induction of IL-6, IL-2R, and IL-10 mRNA ranged from 1 to 4 h.
Maximum expression was observed for all five cytokine genes at 8 h
(Fig. 1). However, the IL-2R gene was maximally expressed at 72 h
upon stimulation with anti-CD3.
The mean maximal level of mRNA production observed upon PHA and
anti-CD3 stimulation of the six genes studies is presented in Fig.
2. IL-2 and IFN-
mRNAs show much
higher absolute maximum levels than IL-10, TNF-
, and IL-6 mRNAs
after PHA or anti-CD3 stimulation. When the four individuals are
compared, there are some differences in the times of maximum production
of specific genes (Table 3), but the
general pattern is similar in most subjects.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Patterns of maximal cytokine mRNA production after
stimulation. The mean (standard error) values of the maximum levels of
each category of mRNA are presented for samples from four donors after
stimulation with PHA (open bars) and anti-CD3 monoclonal antibody
(filled bars).
|
|
The profile of the accumulation of mRNA encoding IL-2R is different
from that of the other genes studied. Within the time period (72 h) and
time intervals examined, IL-2R mRNA, regardless of the stimulus,
demonstrated continued expression rather than transient expression
(Fig. 1). After anti-CD3 stimulation, three of four subjects showed
continuous increases in IL-2R mRNA levels and maximum IL-2R mRNA levels
at 72 h. Cultures from all four subjects after PHA stimulation and
one of four subjects after anti-CD3 clearly demonstrated a decrease in
IL-2R mRNA levels at 24 h, followed by an increase to the maximum
level at 72 h (data not shown). As it has been reported that IL-2
can regulate the expression of its own receptor, such prolonged and
"double peak" production of IL-2R mRNA could be a result of
induction by IL-2 during the preceding 24-h period of PHA or anti-CD3
stimulation.
PBMC from two donors were used for pilot characterization of cytokine
genes' responses to additional stimuli. A microbial antigen (C. albicans), a T-cell and B-cell stimulus (PWM) and IL-2 at high
(1,000-U/ml) and low (10-U/ml) doses were used in addition to PHA and
anti-CD3. A measurable increase in the expression of all six genes
examined was induced by each of the six stimuli except C. albicans which was not able to induce detectable IL-10 mRNA
production (data not shown). The peak responses were observed at 8 h, and the kinetic patterns for the four additional stimuli were
generally parallel to the patterns of responses to PHA and anti-CD3.
Relationship between cytokine and/or cytokine receptor mRNA
expression and cell proliferation.
Lymphocyte proliferation is an
important aspect of the cellular immune response. In parallel
experiments, cell proliferation and induction of maximal levels of mRNA
encoding IL-2, IL-2R, IFN-
, IL-10, TNF-
and IL-6 with each of the
six stimuli were measured. Proliferative stimulation indices were 139.1 (PHA), 13.3 (anti-CD3), 33.4 (PWM), 1.3 (C. albicans), 23.0 (rIL-2, 1,000 U/ml), and 3.3 (rIL-2, 10 U/ml). The maximum levels of
IL-2 and TNF-
mRNA correlated significantly with levels of cell
proliferation (Table 4). However, by
linear regression analysis, no significant correlation was found
between the proliferative stimulation index and the time of cytokine
induction. PHA had a 10-fold-higher stimulation index than anti-CD3.
This effect of PHA was associated with higher expression of IL-10 mRNA
(Table 3) in all samples, which may have contributed to the reduced
proliferative response to anti-CD3.
 |
DISCUSSION |
The coordinated production of cytokines following lymphocyte
activation controls proliferation, differentiation, and function of
cells and is crucial for regulation of the immune response (16). Detailed knowledge of these processes in normal
lymphocytes provides a basis for discerning abnormalities in T-cell
activation and functions of lymphocytes in disease. Indeed, the normal
baseline resting levels of cytokine gene production are only now being defined. Several investigators have reported that unstimulated cells do
not express cytokine mRNA (8, 23, 26). In those studies,
Northern blot analyses were used. In contrast, in our present study
with the highly sensitive RT-PCR method, we observed that unstimulated
and resting PBMC from normal individuals express low levels of all six
cytokine mRNAs. Our findings are consistent with observations for
IFN-
mRNA production in unstimulated spleen cells (24)
and IL-2 and IFN-
mRNA production in rat T-cell clones that had
rested (45). In humans, spontaneous production of IL-6 and
IL-2R mRNA in T cells (19, 22) and of IL-2R mRNA in
monocytes (36) has been reported as well. Our results (Table 2) are compatible with the suggestion (19, 22, 24, 36, 45)
that low mRNA production is caused by low constitutive expression of
these genes in unstimulated PBMC that have rested. However, there may
be some activation during cell separation.
We have examined the kinetics and sequence of the production of five
cytokine genes upon PBMC stimulation in vitro. Our data are generally
compatible with results of previous reports regarding IL-2, IL-2R, and
IFN-
(13, 14, 42). We expanded on prior studies by
including TNF-
, IL-6, and IL-10 genes. By using the highly sensitive
RT-PCR method, we found that gene induction occurs earlier than in
previous studies. All genes studied showed increases within 1 to 4 h after stimulation. Thus, they all belong to the early gene group
(41), although IFN-
, IL-2, and TNF-
genes were the
earliest to be expressed (within 1 h), and IL-2R, IL-6, and IL-10
genes were expressed later.
Maximal production of mRNA encoding IL-2, IL-6, IL-10, TNF-
, and
IFN-
occurred at nearly the same time (an average of 8 h) after
PHA or anti-CD3 stimulation for all cytokine groups. Maximal
PHA-stimulated IL-2R mRNA production occurred at 8 h, but
production continued at an elevated level for 72 h. Stimulation with anti-CD3 induced a continuous increase in mRNA levels during the
72 h period examined. These findings differ from the reported early IL-2R induction that preceded IFN-
and IL-2 mRNA production (26). This is most likely due to differences in stimuli
used
PHA plus phorbol myristate acetate (26) versus PHA and
anti-CD3 used alone here. Several reports have implicated IL-2 in
expression of IL-2R and IFN-
genes (2, 12, 25, 38, 43),
as well as in the induction of IFN-
production (7, 21, 35,
40). Our results for the time of induction and the time and level
of maximal accumulation of mRNA encoding IL-2, IL-2R, and IFN-
(Table 3) do not indicate these relationships. Our data are instead compatible with the data of Krönke et al. (26), who
have demonstrated that the presence of IL-2 is not required for
transcriptional activation of IL-2R and IFN-
genes in fully
stimulated cells. However, our data do not exclude an IL-2 mediated
augmentation of IL-2R and IFN-
gene expression in suboptimally
stimulated cells (26) or a synergy between mitogen and low
doses of IL-2 affecting IFN-
gene expression during the early phases
of a cellular immune response (2).
Our data indicate that the maximum level of production of different
genes may vary when different stimuli are used (Fig. 2). Differences in
these parameters were also noted when PWM was used as the stimulus
(39). With PHA or anti-CD3 stimulation, amounts of mRNA
encoding IL-2 and IFN-
were much higher than those of mRNA encoding
IL-6, IL-10, or TNF-
. This indicates that these two stimuli act
primarily on T cells, which make up the bulk of normal PBMC, and have
much less of an effect on monocytes, the major producers of IL-6,
TNF-
, and IL-10.
Generally, the profile of cytokine gene expression depends at least
partly on cell surface receptor binding of a ligand and activation of
intracellular signaling pathways (16). Different stimuli can
activate T cells in several ways: by antigen binding to the T-cell
receptor-CD3 complex in association with major histocompatibility complexes (42), by modulation of other surface molecules
such as CD2 and CD4 (4), and by bypassing the surface
receptor signaling and directly activating protein kinase C and
intracellular pathways (33). Signals from separate cell
surface receptors are integrated at the level of the responsive gene
(11). Previous data for T-cell lines, T-cell clones, and
PBMC indicate that cells have the capacity to produce many cytokines,
and our data supports the idea that the way cells are activated can
alter the quantitative aspects of cytokine gene expression and protein
secretion (18, 19, 45).
In our present study, some variations between individuals in the time
course of cytokine mRNA production were observed. Diversity between
individuals in immune-cell functional properties like proliferative,
cytotoxic, and cytokine responses is well documented. Usually, such
diversity within populations is presented as a reference range and is
often quite broad. It should be taken into consideration when results
are analyzed and interpreted. In this regard, individual variations
observed in our study group do not justify the suggested classification
of patterns of cytokine gene expression into type 1 (IL-2), which
demonstrates rapid appearance and early maximal accumulation of mRNA,
and type 2 (IFN-
and TNF-
), which demonstrates prolonged gene
production and a late peak time, a generalization based on data from a
single donor (23).
Production of multiple cytokines in stimulated T-cell populations might
be regulated either by a common mechanism or by independent pathways.
Conflicting data in the literature support both options. Data
indicating that various stimulations lead to the synthesis of both IL-2
and IFN-
mRNA (13, 14, 20) support the option of common
mechanisms. This option is additionally supported by sequence data
which show that IL-2 and IFN-
genes have sequence homology at their
5' end (17, 31). Our present data are compatible with this
interpretation and extend them by including TNF-
, IL-6, and IL-10
mRNA, as our time course curves for the five cytokines are essentially
parallel (Fig. 1). Data in support of diverse modes of regulation by
independent pathways have included quantitative differences among
IFN-
, IL-2, and IL-2R produced by PBMC stimulated by anti-CD3 or by
PHA (18, 19). We also observed quantitative differences in
expression of genes for these cytokines and those for IL-6, IL-10, and
TNF-
using the RT-PCR method. Each of the five stimuli were able to
induce expression of the six genes studied (with one
exception
C. albicans did not induce a detectable IL-10 response). Our observations therefore suggest mechanisms whereby cytokines are regulated independently but their transcriptions are
induced simultaneously.
Several specifics should be considered when data from different studies
are compared. PBMC populations are mixed populations of cells. Various
stimuli may cause preferential stimulation of T cells or monocytes in
PBMC. Quantitative differences in gene expression in CD4+
and CD8+ T-cell subsets have also been observed (6,
27), as has the interaction between T-cell subsets which
influence IL-2 and IFN-
gene expression (1). Furthermore,
three types of helper T-cell clones are recognized, according to the
pattern of lymphokine production (3, 11, 32). Th1 cells but
not Th2 cells produce IL-2 and IFN-
. In contrast, Th2 cells but not
Th1 cells produce IL-4. In addition, a Th0 cell subset that produces
almost all cytokines has been described (32). In humans, the
majority of CD4+ T-cell clones obtained from healthy donors
produce IFN-
, IL-2, and IL-4 upon stimulation with various mitogens
(34). In addition, besides regulation at the transcriptional
level, a posttranscriptional regulation that controls the stability of
mRNA also exists and is considered important (28, 44). This
may depend on the mode of stimulation, and the IL-2 mRNA degradation
rate can vary, in contrast to IL-2R mRNA which remains stable
(5). IL-2R mRNA stability may contribute to the prolonged
presence of IL-2R mRNA seen in our studies. In spite of this
complexity, our data should be useful as a basis for defining the
change in cytokine gene expression in PBMC responding to commonly used
stimuli in normal and disease states.
 |
ACKNOWLEDGMENTS |
We thank T. Nguyen for laboratory support, S. Stehn and J. Chung for assistance with data management and statistical help, and J. Moore and D. Mathieson for help with manuscript preparation.
This work was supported by NIH grants AI36086, AI35040, and TW00003.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: CIRID at UCLA,
UCLA School of Medicine, 10833 Le Conte Ave., Los Angeles, CA
90095-1747. Phone: (310) 825-1997. Fax: (310) 206-1318.
Present address: Medical College of Wisconsin, Department of
Pediatrics, Milwaukee, WI 53226.
 |
REFERENCES |
| 1.
|
Arad, G.,
M. Ketzinel,
C. Tal,
R. Nussinovich,
E. Deutsch,
M. Schlesinger,
L. Gerez, and R. Kaempfer.
1995.
Transient expression of human interleukin-2 and interferon- genes is regulated by interaction between distinct cell subsets.
Cell. Immunol.
160:240-247[Medline].
|
| 2.
|
Arad, G.,
R. Nussinovich, and R. Kaempfer.
1995.
Interleukin-2 induces an early step in the activation of interferon- gene expression.
Immunol. Lett.
44:213-216[Medline].
|
| 3.
|
Arai, K.-I.,
F. Lee,
A. Miyajima,
S. Miyatake,
N. Arai, and T. Yokota.
1990.
Cytokines: coordinators of immune and inflammatory responses.
Annu. Rev. Biochem.
59:783-836[Medline].
|
| 4.
|
Bierer, B. E., and S. J. Burakoff.
1989.
T-lymphocyte activation: the biology and function of CD2 and CD4.
Immunol. Rev.
111:267-294[Medline].
|
| 5.
|
Bill, O.,
C. G. Garlisi,
D. S. Grove,
G. E. Holt, and A. M. Mastro.
1994.
IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes.
Cytokine
6:102-110[Medline].
|
| 6.
|
Breen, E. C.,
J. F. Salazar-Gonzalez,
L. P. Shen,
J. A. Kolberg,
M. Urdea,
O. Martinez-Maza, and J. L. Fahey.
1997.
Circulating CD8 T cells show increased interferon-gamma (IFN- ) mRNA expression in HIV infection.
Cell. Immunol.
178:91-98[Medline].
|
| 7.
|
Chan, S. H.,
B. Perussia,
J. W. Gupta,
M. Kobayashi,
M. Pospisil,
H. A. Young,
S. F. Wolf,
D. Young,
S. C. Clark, and G. Trinchieri.
1991.
Induction of interferon production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
J. Exp. Med.
173:869-879[Abstract/Free Full Text].
|
| 8.
|
Cherwinski, H. M.,
J. H. Schumacher,
K. D. Brown, and T. R. Mosmann.
1987.
Two types of mouse helper T cell clone III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.
J. Exp. Med.
166:1229-1244[Abstract/Free Full Text].
|
| 9.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 10.
|
Coffman, R. L.,
B. W. P. Seymour,
D. A. Lehman,
D. D. Hiraki,
J. A. Christiansen,
B. Shrader,
H. M. Cherwinski,
H. F. J. Savelkoul,
F. D. Finkelman,
M. W. Bond, and T. R. Mosmann.
1988.
The role of helper T cell products in mouse B cell differentiation and isotype regulation.
Immunol. Rev.
102:5-28[Medline].
|
| 11.
|
Crabtree, G. R.
1989.
Contingent genetic regulatory events in T lymphocyte activation.
Science
243:355-361[Abstract/Free Full Text].
|
| 12.
|
Depper, J. M.,
W. J. Leonard,
C. Drogula,
M. Krönke,
T. A. Waldmann, and W. C. Greene.
1985.
Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene.
Proc. Natl. Acad. Sci. USA
82:4230-4234[Abstract/Free Full Text].
|
| 13.
|
Efrat, S., and R. Kaempfer.
1984.
Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes.
Proc. Natl. Acad. Sci. USA
81:2601-2605[Abstract/Free Full Text].
|
| 14.
|
Efrat, S.,
S. Pilo, and R. Kaempfer.
1982.
Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and -interferon.
Nature
297:236-239[Medline].
|
| 15.
|
Fan, J.,
H. Z. Bass, and J. L. Fahey.
1993.
Elevated IFN- and decreased IL-2 gene expression are associated with HIV infection.
J. Immunol.
151:5031-5040[Abstract].
|
| 16.
|
Fraser, J. D.,
D. Straus, and A. Weiss.
1993.
Signal transduction events leading to T-cell lymphokine gene expression.
Immunol. Today
14:357-362[Medline].
|
| 17.
|
Fujita, T.,
C. Takaoka,
H. Matsui, and T. Taniguchi.
1983.
Structure of the human interleukin 2 gene.
Proc. Natl. Acad. Sci. USA
80:7437-7441[Abstract/Free Full Text].
|
| 18.
|
Gauchat, J.-F.,
C. Walker,
A. L. De Weck, and B. M. Stadler.
1985.
Stimulation-dependent lymphokine mRNA levels in human mononuclear cells.
Eur. J. Immunol.
18:1441-1446.
|
| 19.
|
Gauchat, J.-F.,
D. Gauchat,
A. L. De Weck, and B. M. Stadler.
1989.
Cytokine mRNA levels in antigen-stimulated peripheral blood mononuclear cells.
Eur. J. Immunol.
19:1079-1085[Medline].
|
| 20.
|
Granelli-Piperno, A.,
L. Andrus, and R. M. Steinman.
1986.
Lymphokine and nonlymphokine mRNA levels in stimulated human T cells.
J. Exp. Med.
163:922-937[Abstract/Free Full Text].
|
| 21.
|
Handa, K.,
R. Suzuki,
H. Matsui,
Y. Shimizu, and K. Kumagai.
1983.
Natural killer (NK) cells as a responder to interleukin 2 (IL-2). II. IL-2-induced interferon- production.
J. Immunol.
130:988-992[Abstract].
|
| 22.
|
Haskill, S.,
C. Johnson,
D. Eierman,
S. Becker, and K. Warren.
1988.
Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.
J. Immunol.
140:1690-1694[Abstract].
|
| 23.
|
Hayashi, S.,
S. Okamura,
C. Kawasaki,
M. Harada, and Y. Niho.
1993.
Sequential expression of lymphokine genes during phytohemagglutinin-stimulated mitogenesis of normal human peripheral mononuclear cells.
Biomed. Pharmacother.
47:155-160[Medline].
|
| 24.
|
Iizawa, Y.,
J. F. Brown, and C. J. Czuprynski.
1992.
Early expression of cytokine mRNA in mice infected with Listeria monocytogenes.
Infect. Immun.
60:4068-4073[Abstract/Free Full Text].
|
| 25.
|
Kasahara, T.,
J. J. Hooks,
S. F. Dougherty, and J. J. Oppenheim.
1983.
Interleukin 2-mediated immune interferon (IFN- ) production by human T cells and T cell subsets.
J. Immunol.
130:1784-1789[Abstract].
|
| 26.
|
Krönke, M.,
W. J. Leonard,
J. M. Depper, and W. C. Greene.
1985.
Sequential expression of genes involved in human T lymphocyte growth and differentiation.
J. Exp. Med.
161:1593-1598[Abstract/Free Full Text].
|
| 27.
|
Leung, J. C. K.,
C. K. W. Lai,
Y. L. Chul,
R. T. H. Ho,
C. H. S. Chan, and K. N. Lai.
1992.
Characterization of cytokine gene expression in CD4+ and CD8+ T cells after activation with phorbol myristate acetate and phytohaemagglutinin.
Clin. Exp. Immunol.
90:147-153[Medline].
|
| 28.
|
Lindstein, T.,
C. H. June,
J. A. Ledbetter,
G. Stella, and C. B. Thompson.
1989.
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.
Science
224:339-343.
|
| 29.
|
Meuer, S. C.,
R. E. Hussey,
D. A. Cantrell,
J. D. Hogdon,
S. F. Schlossman,
K. A. Smith, and E. L. Reinherz.
1984.
Triggering of the T3-Ti antigen receptor complex results in clonal T cell proliferation through an interleukin 2-dependent autocrine pathway.
Proc. Natl. Acad. Sci. USA
81:1509-1513[Abstract/Free Full Text].
|
| 30.
|
Meuer, S. C.,
R. E. Hussey,
M. Fabbi,
D. A. Fox,
O. Acuto,
K. A. Fitzgerald,
J. C. Hogdon,
J. P. Protentis,
S. F. Schlossman, and E. L. Reinherz.
1984.
An alternative pathway of T cell activation: a functional role for the 50 kD T11 sheep erythrocyte receptor protein.
Cell
36:897-906[Medline].
|
| 31.
|
Mita, S.,
S. Maeda,
K. Obaru,
N. Nishino,
K. Shimada,
T. Hirano,
K. Onoue,
T. Ogawa, and H. Ogawa.
1983.
Isolation and characterization of a human interleukin 2 gene.
Biochem. Biophys. Res. Commun.
117:114-121[Medline].
|
| 32.
|
Mosmann, T. R., and R. L. Coffman.
1989.
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.
Annu. Rev. Immunol.
7:145-173[Medline].
|
| 33.
|
Nishizuka, Y.
1984.
The role of protein kinase C in cell surface signal transduction and tumor promotion.
Nature
308:693-698[Medline].
|
| 34.
|
Paliard, X.,
R. De Waal Malefijt,
H. Yssel,
D. Blanchard,
I. Chretien,
J. Abrams,
J. De Vries, and H. Spits.
1988.
Simultaneous production of IL-2, IL-4, and IFN- by activated human CD4+ and CD8+ T cell clones.
J. Immunol.
141:849-855[Abstract].
|
| 35.
|
Pestka, S., and J. A. Langer.
1987.
Interferons and their actions.
Annu. Rev. Biochem.
56:727-777[Medline].
|
| 36.
|
Rambaldi, A.,
D. C. Young,
F. Herrmann,
S. A. Cannistra, and J. D. Griffin.
1987.
Interferon- induces expression of the interleukin 2 receptor gene in human monocytes.
Eur. J. Immunol.
17:153-156[Medline].
|
| 37.
|
Reed, J. C.,
J. D. Alpers,
P. C. Nowell, and R. G. Hoover.
1986.
Sequential expression of proto-oncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.
Proc. Natl. Acad. Sci. USA
83:3982-3986[Abstract/Free Full Text].
|
| 38.
|
Reem, G., and N. H. Yeh.
1984.
Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes.
Science
225:429-430[Abstract/Free Full Text].
|
| 39.
|
Toyoda, M.,
X. Zhang,
A. Petrosian,
O. A. Galera,
S.-J. Wang, and S. C. Jordan.
1994.
Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.
J. Clin. Immunol.
14:178-189[Medline].
|
| 40.
|
Trinchieri, G.,
M. Matsumoto-Kobayashi,
S. C. Clark,
J. Seehra,
L. London, and B. Perussia.
1984.
Response of resting human peripheral blood natural killer cells to interleukin 2.
J. Exp. Med.
160:1147-1169[Abstract/Free Full Text].
|
| 41.
|
Ullman, K. S.,
J. P. Northrop,
C. L. Verweij, and G. R. Crabtree.
1990.
Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.
Annu. Rev. Immunol.
8:421-452[Medline].
|
| 42.
|
Weiss, A.,
J. Imboden,
K. Hardy,
B. Manager,
C. Terhorst, and J. Stobo.
1986.
The role of the T3/antigen receptor complex in T-cell activation.
Annu. Rev. Immunol.
4:593-619[Medline].
|
| 43.
|
Welte, K.,
M. Andreff,
E. Platzer,
K. Holloway,
B. Y. Rubin,
M. A. S. Moore, and R. Mertelsmann.
1984.
Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes.
J. Exp. Med.
160:1390-1403[Abstract/Free Full Text].
|
| 44.
|
Wiskocil, R.,
A. Weiss,
J. Imboden,
R. Kamin-Lewis, and J. Stobo.
1985.
Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and -interferon genes.
J. Immunol.
134:1599-1603[Abstract].
|
| 45.
|
Zhao, Z.,
V. L. Calder,
M. McLauchlan, and S. L. Lightman.
1994.
Differential lymphokine expression by rat antigen-specific CD4+ T cell lines with antigen and mitogen.
Cell. Immunol.
159:220-234[Medline].
|
Clinical and Diagnostic Laboratory Immunology, May 1998, p. 335-340, Vol. 5, No. 3
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Harrington, N. P., Surujballi, O. P., Prescott, J. F.
(2006). CERVINE (CERVUS ELAPHUS) CYTOKINE mRNA QUANTIFICATION BY REAL-TIME POLYMERASE CHAIN REACTION.. J Wildl Dis
42: 219-233
[Abstract]
[Full Text]
-
Audige, A., Schlaepfer, E., Bonanomi, A., Joller, H., Knuchel, M. C., Weber, M., Nadal, D., Speck, R. F.
(2004). HIV-1 Does Not Provoke Alteration of Cytokine Gene Expression in Lymphoid Tissue after Acute Infection Ex Vivo. J. Immunol.
172: 2687-2696
[Abstract]
[Full Text]
-
Sullivan, K. E., Cutilli, J., Piliero, L. M., Ghavimi-Alagha, D., Starr, S. E., Campbell, D. E., Douglas, S. D.
(2000). Measurement of Cytokine Secretion, Intracellular Protein Expression, and mRNA in Resting and Stimulated Peripheral Blood Mononuclear Cells. CVI
7: 920-924
[Abstract]
[Full Text]
-
Breen, E. C., McDonald, M., Fan, J., Boscardin, J., Fahey, J. L.
(2000). Cytokine Gene Expression Occurs More Rapidly in Stimulated Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Persons. CVI
7: 769-773
[Abstract]
[Full Text]
-
Scott, M., Stites, D. P., Moscicki, A.-B.
(1999). Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection. CVI
6: 751-755
[Abstract]
[Full Text]